Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleLaboratory Studies

Copper-62-Labeled Pyruvaldehyde Bis(N4-methylthiosemicarbazonato)copper(II): Synthesis and Evaluation as a Positron Emission Tomography Tracer for Cerebral and Myocardial Perfusion

Mark A. Green, Carla J. Mathias, Michael J. Welch, Andrea H. McGuire, David Perry, Frankee Fernandez-Rubio, Joel S. Perlmutter, Marcus E. Raichle and Steven R. Bergmann
Journal of Nuclear Medicine December 1990, 31 (12) 1989-1996;
Mark A. Green
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carla J. Mathias
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. Welch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea H. McGuire
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Perry
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frankee Fernandez-Rubio
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joel S. Perlmutter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcus E. Raichle
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven R. Bergmann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 31, Issue 12
December 1, 1990
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Copper-62-Labeled Pyruvaldehyde Bis(N4-methylthiosemicarbazonato)copper(II): Synthesis and Evaluation as a Positron Emission Tomography Tracer for Cerebral and Myocardial Perfusion
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Copper-62-Labeled Pyruvaldehyde Bis(N4-methylthiosemicarbazonato)copper(II): Synthesis and Evaluation as a Positron Emission Tomography Tracer for Cerebral and Myocardial Perfusion
Mark A. Green, Carla J. Mathias, Michael J. Welch, Andrea H. McGuire, David Perry, Frankee Fernandez-Rubio, Joel S. Perlmutter, Marcus E. Raichle, Steven R. Bergmann
Journal of Nuclear Medicine Dec 1990, 31 (12) 1989-1996;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Copper-62-Labeled Pyruvaldehyde Bis(N4-methylthiosemicarbazonato)copper(II): Synthesis and Evaluation as a Positron Emission Tomography Tracer for Cerebral and Myocardial Perfusion
Mark A. Green, Carla J. Mathias, Michael J. Welch, Andrea H. McGuire, David Perry, Frankee Fernandez-Rubio, Joel S. Perlmutter, Marcus E. Raichle, Steven R. Bergmann
Journal of Nuclear Medicine Dec 1990, 31 (12) 1989-1996;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Whole-Body PET/CT Evaluation of Tumor Perfusion Using Generator-Based 62Cu-Ethylglyoxal Bis(Thiosemicarbazonato)Copper(II): Validation by Direct Comparison to 15O-Water in Metastatic Renal Cell Carcinoma
  • Theranostics of Malignant Melanoma with 64CuCl2
  • Molecular Imaging of Hypoxia
  • Enhancing Targeted Radiotherapy by Copper(II)diacetyl- bis(N4-methylthiosemicarbazone) Using 2-Deoxy-D-Glucose
  • Delineation of Hypoxia in Canine Myocardium Using PET and Copper(II)-Diacetyl-bis(N4-Methylthiosemicarbazone)
  • Copper-64-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for the Prevention of Tumor Growth at Wound Sites following Laparoscopic Surgery: Monitoring Therapy Response with microPET and Magnetic Resonance Imaging
  • Google Scholar

More in this TOC Section

  • Assessment of Cancer Recurrence in Residual Tumors after Fractionated Radiotherapy: A Comparison of Fluorodeoxyglucose, L-Methionine and Thymidine
  • Monitoring Gene Therapy with Herpes Simplex Virus Thymidine Kinase in Hepatoma Cells: Uptake of Specific Substrates
  • Technetium-99m Labeling and Biodistribution of Anti-TAC Disulfide-Stabilized Fv Fragment
Show more Laboratory Studies

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire